AAOS updates clinical practice guideline for management of hip OA
Click Here to Manage Email Alerts
Key takeaways:
- The AAOS has released an updated clinical practice guideline for management of hip OA.
- The guideline offers the latest evidence-based research and recommendations for nonoperative and operative treatments.
The American Academy of Orthopaedic Surgeons has released an updated clinical practice guideline for management of hip osteoarthritis, according to a press release.
Prior to the latest update, the guideline, which offers recommendations for both nonoperative and operative treatments for hip OA, was last updated in 2017, according to the release. The guideline also offers the latest evidence-based research to help surgeons make decisions to reduce pain, increase function and improve the quality of life in patients with hip OA.
The guideline covers topics such as tranexamic acid, NSAIDs, corticosteroids, hyaluronic acid, diabetes, BMI, opioids and physical, as well as new topics such as social determinants of health and the hip-spine relationship, according to the release.
“The incidence and prevalence of OA of the hip have risen over time and are expected to continue to do so, particularly as life expectancy and obesity rates continue to rise,” Charles P. Hannon, MD, MBA, FAAOS, senior associate consultant in the department of orthopedic surgery at the Mayo Clinic and co-chair of the AAOS clinical practice guideline workgroup, said in the release. “This updated clinical practice guideline provides orthopedic surgeons with the most up-to-date evidence-based practices that they can use to best treat their patients with OA of the hip. It outlines both modifiable risk factors, as well as surgical techniques, and their impact on postoperative outcomes,” Hannon added.
The full clinical practice guideline for clavicle fractures can be found at: https://www.orthoguidelines.org/topic?id=1047&tab=all_guidelines
Read more about
Click Here to Manage Email Alerts